$0.4600
-0.0006-0.13%
Last update: Nov 11, 9:38 AM
Outlook Therapeutics Inc
OTLKNASDAQ
The average analyst price target for Outlook Therapeutics is $9.70, 2008.7% above the current price. Of 7 analysts, 4 rate it Buy and 3 Hold. Targets range from $1 to $31.40. The latest change came on Sep 11, 2026, when Ascendiant Capital raised its price target on Outlook Therapeutics from $10 to $10.50 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months
